1-12 of 12
t-cell therapy
Close
Sort by
Journal Articles

Polatuzumab vedotin as a salvage and bridging treatment in relapsed or refractory large B-cell lymphomas

Clinical Trials & Observations
Nora Liebers, Johannes Duell, Donnacha Fitzgerald, Andrea Kerkhoff, Daniel Noerenberg, Eva Kaebisch, Fabian Acker, Stephan Fuhrmann, Corinna Leng, Manfred Welslau, Jens Chemnitz, Jan-Moritz Middeke, Thomas Weber, Udo Holtick, Ralf Trappe, Roald Pfannes, Ruediger Liersch, Christian Spoer, Stefan Fuxius, Niklas Gebauer, Léandra Caillé, Thomas Geer, Christian Koenecke, Ulrich Keller, Rainer Claus, Dimitrios Mougiakakos, Stephanie Mayer, Andreas Huettmann, Christiane Pott, Arne Trummer, Gerald Wulf, Uta Brunnberg, Lars Bullinger, Georg Hess, Carsten Mueller-Tidow, Bertram Glass, Georg Lenz, Peter Dreger, Sascha Dietrich
Journal: Blood Advances
Blood Adv (2021) 5 (13): 2707–2716.
https://doi.org/10.1182/bloodadvances.2020004155
Published: 2021
Includes: Supplemental data
Journal Articles

Effect of lisocabtagene maraleucel on HRQoL and symptom severity in relapsed/refractory large B-cell lymphoma

Clinical Trials & Observations
Donald L. Patrick, Annette Powers, Monika Parisi Jun, Yeonhee Kim, Jacob Garcia, Christine Dehner, David G. Maloney
Journal: Blood Advances
Blood Adv (2021) 5 (8): 2245–2255.
https://doi.org/10.1182/bloodadvances.2020003503
Published: 2021
Includes: Supplemental data
Journal Articles

Cytokine release syndrome and neurological event costs in lisocabtagene maraleucel–treated patients in the TRANSCEND NHL 001 trial

Jeremy S. Abramson, Tanya Siddiqi, Jacob Garcia, Christine Dehner, Yeonhee Kim, Andy Nguyen, Sophie Snyder, November McGarvey, Matthew Gitlin, Corey Pelletier, Monika P. Jun
Journal: Blood Advances
Blood Adv (2021) 5 (6): 1695–1705.
https://doi.org/10.1182/bloodadvances.2020003531
Published: 2021
Journal Articles

Clinical and radiologic correlates of neurotoxicity after axicabtagene ciloleucel in large B-cell lymphoma

Clinical Trials & Observations
Paolo Strati, Loretta J. Nastoupil, Jason Westin, Luis E. Fayad, Sairah Ahmed, Nathan H. Fowler, Fredrick B. Hagemeister, Hun J. Lee, Swaminathan P. Iyer, Ranjit Nair, Simrit Parmar, Maria A. Rodriguez, Felipe Samaniego, Raphael E. Steiner, Michael Wang, Chelsea C. Pinnix, Sherry Adkins, Catherine M. Claussen, Charles S. Martinez, Misha C. Hawkins, Nicole A. Johnson, Prachee Singh, Haleigh E. Mistry, Sandra Horowitz, Shirley George, Lei Feng, Partow Kebriaei, Elizabeth J. Shpall, Sattva S. Neelapu, Sudhakar Tummala, T. Linda Chi
Journal: Blood Advances
Blood Adv (2020) 4 (16): 3943–3951.
https://doi.org/10.1182/bloodadvances.2020002228
Published: 2020
Journal Articles

Hematopoietic recovery in patients receiving chimeric antigen receptor T-cell therapy for hematologic malignancies

Clinical Trials & Observations
Tania Jain, Andrea Knezevic, Martina Pennisi, Yunxin Chen, Josel D. Ruiz, Terence J. Purdon, Sean M. Devlin, Melody Smith, Gunjan L. Shah, Elizabeth Halton, Claudia Diamonte, Michael Scordo, Craig S. Sauter, Elena Mead, Bianca D. Santomasso, M. Lia Palomba, Connie W. Batlevi, Molly A. Maloy, Sergio Giralt, Eric Smith, Renier Brentjens, Jae H. Park, Miguel-Angel Perales, Sham Mailankody
Journal: Blood Advances
Blood Adv (2020) 4 (15): 3776–3787.
https://doi.org/10.1182/bloodadvances.2020002509
Published: 2020
Includes: Supplemental data
Journal Articles

Complement inhibition does not impair the clinical antiviral capabilities of virus-specific T-cell therapy

Clinical Trials & Observations
Jeremy D. Rubinstein, Xiang Zhu, Carolyn Lutzko, Tom Leemhuis, Jose A. Cancelas, Sonata Jodele, Catherine M. Bollard, Patrick J. Hanley, Stella M. Davies, Michael S. Grimley, Adam S. Nelson
Journal: Blood Advances
Blood Adv (2020) 4 (14): 3252–3257.
https://doi.org/10.1182/bloodadvances.2020002252
Published: 2020
Journal Articles

Results from a multidisciplinary clinic guided by geriatric assessment before stem cell transplantation in older adults

Clinical Trials & Observations
Benjamin A. Derman, Keriann Kordas, Jean Ridgeway, Selina Chow, William Dale, Sang Mee Lee, Elingel Aguada, Andrzej J. Jakubowiak, Jagoda Jasielec, Justin Kline, Satyajit Kosuri, Richard A. Larson, Hongtao Liu, Mylove Mortel, Olatoyosi Odenike, Jennifer Pisano, Peter Riedell, Wendy Stock, Michael R. Bishop, Andrew S. Artz
Journal: Blood Advances
Blood Adv (2019) 3 (22): 3488–3498.
https://doi.org/10.1182/bloodadvances.2019000790
Published: 2019
Includes: Supplemental data
Journal Articles

Adoptive T-cell therapy for pediatric cytomegalovirus-associated retinitis

Clinical Trials & Observations
Shiney Seo, Corey Smith, Christopher Fraser, Rajan Patheja, Shaheen P. Shah, Sweera Rehan, Pauline Crooks, Michelle A. Neller, Rajiv Khanna
Journal: Blood Advances
Blood Adv (2019) 3 (11): 1774–1777.
https://doi.org/10.1182/bloodadvances.2019000121
Published: 2019
Journal Articles

Preclinical development of CD37CAR T-cell therapy for treatment of B-cell lymphoma

Hakan Köksal, Pierre Dillard, Sarah E. Josefsson, Solrun Melkorka Maggadottir, Sylvie Pollmann, Anne Fåne, Yngvild Nuvin Blaker, Klaus Beiske, Kanutte Huse, Arne Kolstad, Harald Holte, Gunnar Kvalheim, Erlend B. Smeland, June H. Myklebust, Else Marit Inderberg, Sébastien Wälchli
Journal: Blood Advances
Blood Adv (2019) 3 (8): 1230–1243.
https://doi.org/10.1182/bloodadvances.2018029678
Published: 2019
Includes: Supplemental data
Journal Articles

Improving T-cell expansion and function for adoptive T-cell therapy using ex vivo treatment with PI3Kδ inhibitors and VIP antagonists

Christopher T. Petersen, Mojibade Hassan, Anna B. Morris, Jasmin Jeffery, Kunhee Lee, Neera Jagirdar, Ashley D. Staton, Sunil S. Raikar, Harold T. Spencer, Todd Sulchek, Christopher R. Flowers, Edmund K. Waller
Journal: Blood Advances
Blood Adv (2018) 2 (3): 210–223.
https://doi.org/10.1182/bloodadvances.2017011254
Published: 2018
Includes: Supplemental data
Journal Articles

Developing T-cell therapies for lymphoma without receptor engineering

Melanie Grant, Catherine M. Bollard
Journal: Blood Advances
Blood Adv (2017) 1 (26): 2579–2590.
https://doi.org/10.1182/bloodadvances.2017009886
Published: 2017
Journal Articles

Long-term control of recurrent or refractory viral infections after allogeneic HSCT with third-party virus-specific T cells

Clinical Trials & Observations
Barbara Withers, Emily Blyth, Leighton E. Clancy, Agnes Yong, Chris Fraser, Jane Burgess, Renee Simms, Rebecca Brown, David Kliman, Ming-Celine Dubosq, David Bishop, Gaurav Sutrave, Chun Kei Kris Ma, Peter J. Shaw, Kenneth P. Micklethwaite, David J. Gottlieb
Journal: Blood Advances
Blood Adv (2017) 1 (24): 2193–2205.
https://doi.org/10.1182/bloodadvances.2017010223
Published: 2017
Includes: Supplemental data